Sponsored Ad

The SABR-COMET clinical trial included 51 patients from the London Regional Cancer Program at London Health Sciences Centre.

Lawson Health Research Institute Perspective London Globe and Mail

london health sciences Centre

Lawson Health Research Institute Perspective London Globe and Mail
Lawson Health Research Institute london health sciences centre